We found that treatment with both FAAH inhibitors and ferroptosis inducers resulted in greater inhibition compared to treatment with a single agent (Fig. S1B), which motivated us to further investigate the synergic effect on RCC inhibition. Here, FAAH is linked to renal cell carcinoma.